> FT-104's binding constant (Ki) for the 5HT2A receptor is 120 nM, which indicates a potency similar to psilocybin
> The elimination of FT-104 from the bloodstream has a half-life (t1/2) of 40min, which compares to psilocybin with a half-life on the order of 120min
> FT-104 will likely produce a reliably short-duration of psychedelic experience in the range of two to four hours, which is approximately half the duration of psilocybin
Pretty interesting to imagine a shrooms-like experience in a shorter time window. I could see a future where these are served at bars/dispensaries like cocktails
1 comment
[ 3.2 ms ] story [ 15.0 ms ] thread> The elimination of FT-104 from the bloodstream has a half-life (t1/2) of 40min, which compares to psilocybin with a half-life on the order of 120min
> FT-104 will likely produce a reliably short-duration of psychedelic experience in the range of two to four hours, which is approximately half the duration of psilocybin
Pretty interesting to imagine a shrooms-like experience in a shorter time window. I could see a future where these are served at bars/dispensaries like cocktails